- The 7th biennial conference will bring together more than 1,500 delegates from over 40 countries to advance integrated diagnostics, health security and sustainable laboratory systems across Africa.
- The African Society for Laboratory Medicine (ASLM) and Roche Diagnostics renew their partnership to strengthen Africa’s laboratory and diagnostic capabilities.
- The collaboration will improve access to reliable diagnostics and strengthen Africa’s ability to detect and respond to health threats.
The African Society for Laboratory Medicine (ASLM) will convene its 7th Biennial Conference, ASLM2026, in Cape Town from 8–11 December, bringing together delegates from over 60 countries across Africa and beyond to advance the role of integrated diagnostics in Africa’s health security and sustainable development.
Held under the theme “Integrated Diagnostics for Health Security: Investing in Sustainable Impact”, the conference will bring together ministers of health, public health institutes, scientists, laboratory leaders, policymakers, academics, development partners, multilateral organisations and private sector stakeholders.
It will provide a platform for scientific exchange, policy dialogue and collaboration on strengthening diagnostic infrastructure and building more resilient health systems across Africa.
The discussions will address some of the continent’s most pressing health priorities, including early disease detection, epidemic preparedness and response, antimicrobial resistance (AMR), sustainable investment in laboratory systems, workforce development, regional manufacturing, digital health, artificial intelligence and data-driven approaches.
The conference will also examine how countries can strengthen laboratory networks and sustain diagnostic capacity beyond emergency funding cycles.
Against this backdrop, ASLM and Roche Diagnostics are continuing their collaboration to advance sustainable integrated diagnostics and strengthen Africa’s health security.
The partnership focuses on developing skilled laboratory leaders, supporting the integration of testing for multiple diseases and building diagnostic systems that can respond to evolving healthcare needs.
Roche has partnered with African Ministries of Health and other stakeholders to strengthen access to integrated healthcare services, including screening, early detection and care for cancer and non-communicable diseases.
The organisation has also played a role in expanding diagnostic capacity across Sub-Saharan Africa through the establishment of more than 100 PCR testing laboratories, supporting millions of HIV and early infant diagnosis tests while strengthening laboratory infrastructure and building the skills of thousands of laboratory professionals.
ASLM’s work is guided by a vision of making quality diagnostics a reality for every African, built around developing a skilled and professional laboratory workforce; expanding access to affordable, safe and quality-assured diagnostics; strengthening the reliability and responsiveness of national diagnostic services; and advancing African leadership in laboratory medicine.
Endorsed by the African Union, ASLM works alongside Africa CDC, Ministries of Health and industry partners to translate these priorities into stronger, more resilient health systems across the continent. ASLM2026 will provide an opportunity to advance this agenda through collaboration, knowledge exchange and renewed commitment to sustainable diagnostic capacity.
“Strengthening diagnostics is indispensable to Africa’s ability to anticipate, detect and respond to health crises whether endemic, epidemic or pandemic,” says Mr Nqobile Ndlovu, Chief Executive Officer at ASLM. “At the same time, investing in integrated and resilient diagnostic systems is fundamental to improving patient outcomes, accelerating progress toward Universal Health Coverage, and strengthening health security across the continent.”
“Africa’s diagnostic systems need to be built for the long term, with the skills, infrastructure and resources to respond to changing healthcare needs,” says Dr Rishubh Gupta, Head of Roche Diagnostics, Africa. “Our partnership with ASLM is about strengthening local expertise, making better use of existing diagnostic technologies and helping countries build laboratory services that are sustainable, accessible and less dependent on external funding.”
Through the continued collaboration, ASLM and Roche Diagnostics aim to contribute to stronger laboratory systems across Africa, combining expertise, resources and partnerships to advance integrated diagnostics, strengthen local capacity and support more sustainable health systems.
About the African Society for Laboratory Medicine (ASLM)
The African Society for Laboratory Medicine (ASLM) is a pan-African organisation dedicated to improving laboratory services and systems across the continent.
ASLM works in partnership with governments, international organizations, and healthcare providers to enhance laboratory capacity and improve health outcomes.
About ASLM2026
The 7th Biennial Conference of the African Society for Laboratory Medicine (ASLM2026) will be held from 08–11 December 2026 at the Cape Town International Convention Centre in Cape Town. The conference will convene more than 1,500 participants from over 40 countries, including leaders in laboratory medicine, public health, research, policy, and industry.
ASLM2026 will provide a global platform for advancing integrated diagnostics, strengthening resilient health systems, and accelerating collaborative solutions to public health challenges across Africa and beyond through high-level plenaries, scientific sessions, exhibitions, workshops, and strategic networking opportunities.
About Roche Africa
With a uniquely broad spectrum of innovative solutions, Roche is a leading healthcare company that has for over 125 years been active in the discovery, development, manufacture and marketing of healthcare solutions. The company’s products and services address prevention, diagnosis, and treatment of diseases, thus enhancing well-being and quality of life.
Headquartered in Basel, Switzerland, Roche employs over 85 000 people globally and sells its products in over 150 countries. Roche’s multinational presence reinforces its ability to offer healthcare solutions worldwide and to anticipate needs in all regions of the world.
Roche Africa employs over 400 people within the pharmaceutical and diagnostics divisions. The company is committed to maintaining high ethical standards in its business dealings and its efforts to protect the environment.
Roche’s purpose is to develop medicines and diagnostics that will enable patients across Africa to live longer, better lives. The company strives to address unmet medical needs through excellence in science – from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring.
